
Leah H. Schlientz
Examiner (ID: 5396)
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 804 |
| Issued Applications | 283 |
| Pending Applications | 116 |
| Abandoned Applications | 429 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18019142
[patent_doc_number] => 20220370641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => SILICONE-BASED DYES WITH SHORT WAVELENGTH INFRARED ABSORPTION AND EMISSION AND METHODS FOR MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/662574
[patent_app_country] => US
[patent_app_date] => 2022-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12050
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17662574
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/662574 | Silicone-based dyes with short wavelength infrared absorption and emission and methods for making and using the same | May 8, 2022 | Issued |
Array
(
[id] => 18275512
[patent_doc_number] => 11614451
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-28
[patent_title] => Targeting ligands for tau pathology
[patent_app_type] => utility
[patent_app_number] => 17/739031
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 24
[patent_no_of_words] => 16103
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17739031
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/739031 | Targeting ligands for tau pathology | May 5, 2022 | Issued |
Array
(
[id] => 18075975
[patent_doc_number] => 20220401587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => LOW X-RAY ATTENUATION CHANGE HARD SHELLED ORAL CONTRAST MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/736957
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736957
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736957 | LOW X-RAY ATTENUATION CHANGE HARD SHELLED ORAL CONTRAST MATERIAL | May 3, 2022 | Abandoned |
Array
(
[id] => 19263764
[patent_doc_number] => 20240207461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => RADIOACTIVE ANTITUMOR AGENT
[patent_app_type] => utility
[patent_app_number] => 18/556577
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21411
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556577
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/556577 | RADIOACTIVE ANTITUMOR AGENT | Apr 20, 2022 | Pending |
Array
(
[id] => 17988936
[patent_doc_number] => 20220354973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => IRON NITRIDE NANOPARTICLE SUSPENSION
[patent_app_type] => utility
[patent_app_number] => 17/659953
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17659953
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/659953 | IRON NITRIDE NANOPARTICLE SUSPENSION | Apr 19, 2022 | Pending |
Array
(
[id] => 19297778
[patent_doc_number] => 20240226344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => NUCLEIC ACID ORIGAMI PLATFORMS AND THEIR USES
[patent_app_type] => utility
[patent_app_number] => 18/286003
[patent_app_country] => US
[patent_app_date] => 2022-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18286003
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/286003 | NUCLEIC ACID ORIGAMI PLATFORMS AND THEIR USES | Apr 11, 2022 | Pending |
Array
(
[id] => 17881237
[patent_doc_number] => 20220296714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => TARGETED NANO-PHOTOMEDICINES FOR PHOTODYNAMIC THERAPY OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/714251
[patent_app_country] => US
[patent_app_date] => 2022-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10018
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714251
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/714251 | TARGETED NANO-PHOTOMEDICINES FOR PHOTODYNAMIC THERAPY OF CANCER | Apr 5, 2022 | Abandoned |
Array
(
[id] => 17733366
[patent_doc_number] => 20220218825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => SURFACTANT MICROBUBBLES AND PROCESS FOR PREPARING AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/657028
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17657028
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/657028 | SURFACTANT MICROBUBBLES AND PROCESS FOR PREPARING AND METHODS OF USING THE SAME | Mar 28, 2022 | Abandoned |
Array
(
[id] => 19299955
[patent_doc_number] => 20240228524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => IRON(III) MACROCYCLIC COMPLEXES WITH MIXED HYROXYL PENDANTS AS MRI CONTRAST AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/551458
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551458
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551458 | IRON(III) MACROCYCLIC COMPLEXES WITH MIXED HYROXYL PENDANTS AS MRI CONTRAST AGENTS | Mar 20, 2022 | Pending |
Array
(
[id] => 17702957
[patent_doc_number] => 20220202963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => RADIOLABELED COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/692632
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12927
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692632
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/692632 | RADIOLABELED COMPOUNDS | Mar 10, 2022 | Abandoned |
Array
(
[id] => 17850393
[patent_doc_number] => 20220280434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => RAPIDLY DISINTEGRATING GELATINOUS COATED TABLETS
[patent_app_type] => utility
[patent_app_number] => 17/686962
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 229
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17686962
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/686962 | RAPIDLY DISINTEGRATING GELATINOUS COATED TABLETS | Mar 3, 2022 | Abandoned |
Array
(
[id] => 19104694
[patent_doc_number] => 11957767
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => Compound targeting prostate specific membrane antigen, and preparation method and application thereof
[patent_app_type] => utility
[patent_app_number] => 18/548546
[patent_app_country] => US
[patent_app_date] => 2022-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 5553
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548546
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548546 | Compound targeting prostate specific membrane antigen, and preparation method and application thereof | Feb 26, 2022 | Issued |
Array
(
[id] => 19338580
[patent_doc_number] => 12048751
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-30
[patent_title] => Compositions and methods for assessing gut function
[patent_app_type] => utility
[patent_app_number] => 17/652037
[patent_app_country] => US
[patent_app_date] => 2022-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6379
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17652037
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/652037 | Compositions and methods for assessing gut function | Feb 21, 2022 | Issued |
Array
(
[id] => 17944458
[patent_doc_number] => 20220331475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => Two Component Sealing Systems Including Synthetic Matrices and Biosynthetic Adhesives
[patent_app_type] => utility
[patent_app_number] => 17/667787
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3483
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667787
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/667787 | Two Component Sealing Systems Including Synthetic Matrices and Biosynthetic Adhesives | Feb 8, 2022 | Pending |
Array
(
[id] => 18536167
[patent_doc_number] => 20230241255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => MAGNETIC RESONANCE CONTRAST AGENTS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/588458
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588458
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588458 | MAGNETIC RESONANCE CONTRAST AGENTS AND METHODS THEREOF | Jan 30, 2022 | Pending |
Array
(
[id] => 17593653
[patent_doc_number] => 20220143226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => USE OF TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/582283
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9777
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17582283
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/582283 | USE OF TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES | Jan 23, 2022 | Pending |
Array
(
[id] => 17733391
[patent_doc_number] => 20220218850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => Methods and Compositions for Two-Stage Microbubble Delivery of Active Agents
[patent_app_type] => utility
[patent_app_number] => 17/574790
[patent_app_country] => US
[patent_app_date] => 2022-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29757
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17574790
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/574790 | Methods and Compositions for Two-Stage Microbubble Delivery of Active Agents | Jan 12, 2022 | Pending |
Array
(
[id] => 19201543
[patent_doc_number] => 20240173442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => COMBINATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/271928
[patent_app_country] => US
[patent_app_date] => 2022-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18271928
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/271928 | COMBINATION THERAPY | Jan 10, 2022 | Pending |
Array
(
[id] => 20534526
[patent_doc_number] => 12551577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-17
[patent_title] => 7-ethyl-10-hydroxycamptothecin drug precursor with fluorescence activity, and preparation method and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/927722
[patent_app_country] => US
[patent_app_date] => 2021-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 0
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17927722
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/927722 | 7-ethyl-10-hydroxycamptothecin drug precursor with fluorescence activity, and preparation method and use thereof | Dec 29, 2021 | Issued |
Array
(
[id] => 17519359
[patent_doc_number] => 20220105207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => Macrocyclic Agents for Targeted Dual-Modality PET and MRI Imaging of Cancer
[patent_app_type] => utility
[patent_app_number] => 17/552984
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552984
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/552984 | Macrocyclic Agents for Targeted Dual-Modality PET and MRI Imaging of Cancer | Dec 15, 2021 | Abandoned |